Cardiology update

Published	Meeting	Title
Total : 46
03/2004	ACC	Implantable cardioverter defibrillators for primary prevention of sudden death: Implications of the SCD-HeFT and DINAMIT trials Reported and discussed by: WILLIAM G. STEVENSON, M.D. Originally presented by: Gust Bardy, MD (Sudden Cardiac Death in Heart Failure Trial) and Stefan H. Hohnloser, MD and Stuart J. Connolly, MD (Defibrillator in Acute Myocardial Infarction Trial)
03/2004	ACC	The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial Reported and discussed by: SAMUEL Z. GOLDHABER, MD Originally presented by: Barry M. Massie, MD
08/2003	ESC	The CHARM Program Reported and discussed by: SCOTT D. SOLOMON, MD Originally presented by: Karl Swedberg, MD; Christopher Granger, MD; John McMurray, MD; Salim Yusuf, MD; Marc A. Pfeffer, MD, PhD
08/2003	ESC	The Optimal Beta-blocker for Heart Failure: Does COMET Answer the Question? Reported and discussed by: JAMES FANG, MD Originally presented by: Philip A. Poole-Wilson, MD
03/2003	ACC	The EPHESUS Trial Reported and discussed by: SCOTT D. SOLOMON, MD Originally presented by: Bertrand Pitt, MD
03/2003	ACC	SPORTIF III: Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Nonvalvular Atrial Fibrillation Reported and discussed by: SAMUEL Z. GOLDHABER, MD Originally presented by: Jonathan L. Halperin, M.D. on behalf of the SPORTIF III Investigators
03/2003	ACC	Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure: Preliminary Results of the COMPANION Trial Presented and discussed by: ANJU NOHRIA, M.D. Originally presented by: Arthur Feldman, M.D. and Michael Bristow, M.D.
11/2002	AHA	REPLACE 2: The role of bivalirudin in PCI Reported and discussed by: ROBERT P. GIUGLIANO, MD, SM Originally presented by: A. Michael Lincoff, M.D.
11/2002	AHA	CREDO: Clopidogrel for the Reduction of Events During Observation Presented and discussed by: JOSHUA A. BECKMAN, MD, MS Originally presented by: Steven R. Steinhubl, MD
11/2002	AHA	TREADMILL: Cholesterol Reduction with Atorvastatin Improves Walking Distance in Patients with Peripheral Arterial Disease Presented and discussed by: JOSHUA A. BECKMAN, MD, MS Originally presented by: Emile R. Mohler, III, MD,William R. Hiatt, MD, and Mark A. Creager, MD
11/2002	AHA	PROSPER and ALLHAT-LLT* Is the bloom off the statin rose? Presented and discussed by: RICHARD C. PASTERNAK, MD PROSPER was originally presented by: James Shepherd, MD
03/2002	ACC	WIZARD: The Weekly Intervention with Zithromax for Atherosclerosis and its Related Disorders Study Reported and discussed by: JOSHUA A. BECKMAN, MD Originally presented by: M. Dunne, MD, C. OConnor, MD
03/2002	ACC	OVERTURE: Introduction or Finale to Vasopeptidase Inhibition in Heart Failure? Reported and discussed by: MICHAEL M. GIVERTZ, MD Originally presented by: Milton Packer, MD
03/2002	ACC	The INTERACT Trial Reported and discussed by: FREDERICK G.P. WELT, M.D., and DANIEL I. SIMON, M.D. Originally presented by: Shaun Goodman, M.D., on behalf of the INTERACT Investigators
03/2002	ACC	Implantable devices for heart failure: Combining defibrillators with cardiac resynchronization therapy Reported and discussed by: BRUCE KOPLAN, M.D. and WILLIAM G. STEVENSON, M.D. Originally presented by: James B. Young, MD
03/2002	ACC	The Meaning of LIFE: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) Trial Reported and discussed by: SCOTT D. SOLOMON, MD Originally presented by: Bjorn Dahlof, MD, and Richard Devereaux, MD
03/2002	ACC	Rate Control Versus Rhythm Control for Atrial Fibrillation Reported and discussed by: WILLIAM G. STEVENSON, M.D. Originally presented by: D. George Wyse, M.D., Harry J. Crijns, M.D., Isabelle C. Van Gelder, M.D.
03/2002	ACC	Prophylactic ICDs in Patients with MI and Reduced Left Ventricular Fraction: Results of the MADIT II Trial Reported and discussed by: KYOKO SOEJIMA, MD, WILLIAM G. STEVENSON, MD Originally presented by: Arthur Moss, MD
11/2001	AHA	Prophylactic Class III antiarrhythmic drug therapy after myocardial infarction: ALIVE or dead? Reported and discussed by: JOHN MCMURRAY, MD, FRCP, FESC, FACC Originally presented by: A. J. Camm, MD
11/2001	AHA	The Heart Protection Study at the AHA: Yes (statins) and No (vitamins), definitely Reported and discussed by: JORGE PLUTZKY, MD. Originally presented by: Rory Collins, MD
09/2001	ESC	Percutaneous Coronary Intervention in the Clopidogrel in Unstable Angina to Prevent Recurrent Events (PCI-CURE) Trial Reported and discussed by: CHRISTOPHER P. CANNON, MD Originally presented by: Shamir R. Mehta, MD
09/2001	ESC	Trials of Adjunctive Therapy for Pharmacologic Reperfusion of ST-Elevation MI: GUSTO-V, ASSENT-3, HERO-2 Reported and discussed by: ELLIOTT M. ANTMAN, MD Originally presented by: Michael Lincoff, MD, Frans Van de Werf, MD, Harvey White, MD
09/2001	ESC	The RAVEL Trial: Restenosis Defeated Reported and discussed by: DANIEL I. SIMON, MD, ALEXANDRE C. ZAGO, MD, and RAILA EHLERS, MD. Originally presented by: Marie Claude Morice, MD, on behalf of P.W. Serruys, MD, J.E. Sousa, MD, J. Fajadet, MD, M. Perin, MD, E. Ban Hayashi, MD, A. Colombo, MD, G. Schuler, MD, P. Barragan, MD, C. Bode, MD, and the RAVEL Investigators
03/2001	ACC	CAPRICORN: The Effect of Carvedilol in Patients with Left Ventricular Dysfunction Following Acute Myocardial Infarction Reported and discussed by:PETER H. STONE, MD Originally presented by: Henry Dargie, MD
03/2001	ACC	TRAFFIC: The First Prospective Therapeutic Angiogenesis Trial in Intermittent Claudication Reported and discussed by: JOSHUA A. BECKMAN, MD. Originally presented by: Robert Lederman, MD, Farrell O. Mendelson, MD, R. David Anderson, MD, Jorge F. Saucedo, MD, Alan N. Tenaglia, MD, James B. Hermiller, MD, Krishna Rocha-Singh, MD, William Hillegass, MD, William R. Hiatt, MD, Thomas E. Moon, MD, M.J.Whitehouse, MD, Brian H. Annex, MD
03/2001	ACC	Statins, C-Reactive Protein, and Atherothrombosis: The Pravastatin Inflammation/CRP Evaluation (PRINCE) and the AFCAPS/TexCAPS CRP Substudy Reported and discussed by: PAUL M RIDKER, MD, MPH. Originally presented by: Paul M. Ridker, MD
03/2001	ACC	The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial Reported and discussed by: CHRISTOPHER P. CANNON, M.D. Originally presented by: Salim Yusuf, MD
03/2001	ACC	Biventricular pacing therapy for heart failure: The MIRACLE trial Reported and discussed by: WILLIAM G. STEVENSON, MD, and HAFIZA KHAN, MD. Original presenter: William Abraham, MD
03/2001	ACC	A Placebo-Controlled Safety and Pharmacology Study of ALT-711 in Older Patients With Stiffened Cardiovasculature Reported and discussed by: GARY F. MITCHELL, MD. Originally presented by: David A. Kass, MD
11/2000	AHA	Valsartan in Heart Failure Trial (Val-HeFT): To Add or Not To Add? Reported and discussed by: JAMES C. FANG, MD Originally presented by: Jay Cohn, MD
11/2000	AHA	MIRACL: The Statin Story Continues Reported and discussed by: JORGE PLUTZKY, MD. Originally presented by: A. Olsson, MD, G. Schwartz, MD
08/2000	ESC	Beta-Blockers for Heart Failure COPERNICUS Reinforces and Expands their Role Reported and discussed by: JOHN McMURRAY, MD, FRCP, FESC, FACC. Originally presented by: Milton Packer, MD
08/2000	ESC	The 4th Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO IV-ACS): What Happened? Reported and discussed by: CHRISTOPHER P. CANNON, M.D. Based on presentations by: Profs. Maarten Simoons and Lars Wallentin
08/2000	ESC	National Investigators Collaborating on Enoxaparin (NICE-3) Reported and discussed by: SAMUEL Z. GOLDHABER, MD. Original presenter: James J. Ferguson, MD
03/2000	ACC	The Second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) Reported and discussed by: MARC A PFEFFER, MD, PhD. Originally presented by: Milton Packer, MD
03/2000	ACC and SCAI	Late-Breaking Trials of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes: ESPRIT, PARAGON B, and Second Symphony Reported and discussed by: CHRISTOPHER P. CANNON, M.D. Originally presented by: James Tcheng, MD, Robert Harrington, MD, Kristin Newby, MD
03/2000	ACC	If you cant beat em, join em: Combination niacin/statin formulation shows pronounced effects on major lipoproteins and is well tolerated Reported and discussed by: JOSHUA A. BECKMAN, MD. Originally presented by: Moti L. Kashyap, MD, Rosemary Evans, MD, Phillip D. Simmons, Roger M. Kohler, Mark E. McGovern, MD
03/2000	ACC	OPTIME Not prime time for intravenous inotropic therapy Reported and discussed by: LYNNE WARNER STEVENSON, MD. Originally presented by: M. Gheorgiade, MD
03/2000	ACC	Argatroban in the management of heparin-induced thrombocytopenia Reported and discussed by: SAMUEL Z. GOLDHABER, MD. Originally presented by: Bruce E. Lewis, MD, Diane E. Wallis, MD,William Matthal, MD, for the ARG-911 Study Investigators
11/1999	AHA	Inhibition of the Renin-angiotensin System and Congestive Heart Failure: The ELITE II Results Reviewed and discussed by: SCOTT D. SOLOMON, MD. Originally presented by: Bertram Pitt, MD
03/1999	ACC	The Multicenter Unsustained Tachycardia Trial (MUSTT) Reported and discussed by: WILLIAM G. STEVENSON, M.D. Presented by: Alfred Buxton, M.D. on behalf of the MUSTT investigators
03/1999	ACC	The MERIT of Beta-blockade in Heart Failure Reported and discussed by: LYNNE WARNER STEVENSON, MD. Presented by: A. Hjalmarson, MD
11/1998	AHA	New Strategies for the Treatment of Acute Coronary Syndromes Reported and discussed by: CHRISTOPHER P. CANNON, MD. Presented by: Joseph Ornato, MD, Christopher P. Cannon, MD, Elliott M. Antman, MD, Eugene Braunwald, MD, Eric J. Topol, MD, James T. Willerson, MD
11/1998	AHA	Stent Mania: Proving Efficacy and Improving Safety Reported and discussed by: DANIEL I. SIMON, MD, FACC. Originally presented by: Cindy L. Grines, MD, A. Michael Lincoff, MD
11/1998	AHA	The Veterans Administration-HDL Intervention Trial (VA-HIT) Reported and discussed by: JORGE PLUTZSKY, MD. Presented by: Hanna Rubins, MD on behalf of Sander Robins, MD, and the VA-HIT Investigators
11/1997	AHA	Selecting Coronary Stents: A review of the trials comparing new stent designs with the gold standard Reported and discussed by: CAMPBELL ROGERS, MD
Total : 46